Cancer Gene Therapy : Impact Factor & More
eISSN: 1476-5500pISSN: 0929-1903
Share this on:
Key Metrics
CiteScore 
8.4
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q2Cancer Research
SNIP
0.97
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Gene Therapy
Cancer Gene Therapy Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cancer Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Gene Therapy
The role of STAT3 in regulating ferroptosis in cancer: molecular mechanisms and targeted therapeutic perspectives.
- 12 May 2026
- Cancer gene therapy
Retraction Note: LncRNA SPRY4-IT was concerned with the poor prognosis and contributed to the progression of thyroid cancer.
- 11 May 2026
- Cancer gene therapy
Dual PI3K/AKT/mTOR and CDK4/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma.
- 8 May 2026
- Cancer gene therapy
MSTO1 modulates RAD51 activity to safeguard mitochondrial DNA integrity and control immune responses.
- 7 May 2026
- Cancer gene therapy
YTHDF1/SLC39A4 signaling axis promotes gastric cancer cell proliferation by suppressing cuproptosis ex vivo and in vitro.
- 29 Apr 2026
- Cancer gene therapy
Preclinical development of a mutant KRAS targeting therapeutic cancer vaccine.
- 28 Apr 2026
- Cancer gene therapy
The role of STAT3 in regulating ferroptosis in cancer: molecular mechanisms and targeted therapeutic perspectives.
- 12 May 2026
- Cancer gene therapy
Retraction Note: LncRNA SPRY4-IT was concerned with the poor prognosis and contributed to the progression of thyroid cancer.
- 11 May 2026
- Cancer gene therapy
Dual PI3K/AKT/mTOR and CDK4/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma.
- 8 May 2026
- Cancer gene therapy
MSTO1 modulates RAD51 activity to safeguard mitochondrial DNA integrity and control immune responses.
- 7 May 2026
- Cancer gene therapy
YTHDF1/SLC39A4 signaling axis promotes gastric cancer cell proliferation by suppressing cuproptosis ex vivo and in vitro.
- 29 Apr 2026
- Cancer gene therapy
Preclinical development of a mutant KRAS targeting therapeutic cancer vaccine.
- 28 Apr 2026
- Cancer gene therapy
FAQs on Cancer Gene Therapy
How long has Cancer Gene Therapy been actively publishing? 
What is the publishing frequency of Cancer Gene Therapy?
How many articles did Cancer Gene Therapy publish last year?
What is the eISSN & pISSN for Cancer Gene Therapy?
What is Citescore for Cancer Gene Therapy?
What is SNIP score for Cancer Gene Therapy?
What is the SJR for Cancer Gene Therapy?
Who is the publisher of Cancer Gene Therapy?
